INR 909.8
(-1.02%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.57 Billion INR | -40.03% |
2022 | 2.62 Billion INR | 33.37% |
2021 | 1.96 Billion INR | 33.33% |
2020 | 1.47 Billion INR | 18.32% |
2019 | 1.24 Billion INR | 28.23% |
2018 | 972.93 Million INR | 492.46% |
2017 | 164.22 Million INR | -54.45% |
2016 | 360.49 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 968.71 Million INR | 0.95% |
2024 Q1 | 392.44 Million INR | 4.06% |
2023 Q3 | 893.98 Million INR | 2.82% |
2023 Q4 | 377.14 Million INR | -57.81% |
2023 Q1 | 787.94 Million INR | 11.09% |
2023 FY | 1.57 Billion INR | -40.03% |
2023 Q2 | 869.47 Million INR | 10.35% |
2022 Q3 | 669.6 Million INR | 0.5% |
2022 Q1 | 579.78 Million INR | 9.63% |
2022 Q4 | 709.3 Million INR | 5.93% |
2022 Q2 | 666.29 Million INR | 14.92% |
2022 FY | 2.62 Billion INR | 33.37% |
2021 Q4 | 528.84 Million INR | 10.38% |
2021 FY | 1.96 Billion INR | 33.33% |
2021 Q3 | 479.1 Million INR | 4.93% |
2021 Q2 | 456.58 Million INR | -9.36% |
2021 Q1 | 503.72 Million INR | 39.34% |
2020 Q4 | 361.5 Million INR | 0.0% |
2020 FY | 1.47 Billion INR | 18.32% |
2019 FY | 1.24 Billion INR | 28.23% |
2019 Q4 | 1.47 Billion INR | 0.0% |
2018 FY | 972.93 Million INR | 492.46% |
2017 FY | 164.22 Million INR | -54.45% |
2016 FY | 360.49 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Dr. Lal PathLabs Limited | 7.03 Billion INR | 77.64% |
Metropolis Healthcare Limited | 3.3 Billion INR | 52.313% |
Thyrocare Technologies Limited | 1.59 Billion INR | 1.549% |
Vijaya Diagnostic Centre Limited | 985.79 Million INR | -59.682% |
Vimta Labs Limited | 450.67 Million INR | -249.289% |